XML 147 R103.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE CAPITAL (Details Narrative) - CAD ($)
12 Months Ended
Mar. 22, 2021
Feb. 04, 2021
Aug. 15, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]            
Value of stock issued for exercise of warrants       $ 4,929,790    
Number of stock units issued for regulation financing       6,488,691 511,299  
Stock units issued during period value regulation financing       $ 18,815,485 $ 1,518,845  
Share capital issuance, description       Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.  
Warrant derivative liability       $ 8,261,511    
Number of stock issued for private placement       5,095,966   2,810,300
Value of stock issued for private placement       $ 25,538,213    
Number of stock issued for cash proceeds         192,308  
Value of stock issued for cash proceeds         $ 500,000  
Number of stock issued for debt settlement         111,082  
Recongnized loss         $ 344,354  
Comprehensive loss         38,879  
Proceeds from issuance of notes payable       123,000 $ 1,137,978
Subscription receivable           153,566
Amounts payable, related party transactions       475,628 $ 9,681
Shares issued of settlement trades payable, shares           9,065
[custom:SharesIssuedOfSettlementTradesPayable]           $ 22,662
Trades payable per share           $ 2.50
Shares issued of settlement convertible debentures and accrued interest, shares           423,698
Shares issued of settlement convertible debentures           $ 740,000
Gain loss on settlement of debt           $ 319,246
Purchases of exercise of warrants, shares           63,388
Purchases of exercise of warrants           $ 8,833
Capital reserve       $ 6,406,117 $ 3,024,007 212,908
Number of options outstanding, Granted       247,826 492,000  
Weighted average exercise price, Granted       $ 10.12 $ 3.08  
Adjustments for share-based payments       $ 3,952,595 $ 2,668,464 761,559
Weighted average remaining contractual life of outstanding share options       1 year 2 months 12 days 1 year 25 days  
Warrants issued 1,200,000          
Warrants held in escrow 900,000          
Warrants [Member]            
IfrsStatementLineItems [Line Items]            
Warrants Expiration Date Description       During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021.    
Stock Options [Member]            
IfrsStatementLineItems [Line Items]            
Adjustments for share-based payments       $ 1,660,894 $ 1,724,853 599,701
Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of accelerated vesting shares       323,661    
Number of shares vested       124,999    
Number of shares granted post consolidation       348,826    
Share based payment expense       $ 2,291,701 $ 943,611 $ 161,858
Employee [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       30,000 89,000  
Weighted average exercise price, Granted       $ 13.20 $ 2.50  
Stock option exercisable year       10 years 10 years  
Consultant [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       10,000 120,000  
Weighted average exercise price, Granted       $ 13.90 $ 3.85  
Stock option exercisable year       5 years 10 years  
Employees and Consultant [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       182,000    
Weighted average exercise price, Granted       $ 10.15    
Stock option exercisable year       10 years    
Employee One [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       25,826 200,000  
Weighted average exercise price, Granted       $ 4.84 $ 3.20  
Stock option exercisable year       5 years 5 years  
Employee Two [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         33,000  
Weighted average exercise price, Granted         $ 2.50  
Stock option exercisable year         10 years  
Consultant One [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         50,000  
Weighted average exercise price, Granted         $ 2.15  
Stock option exercisable year         10 years  
Employee and Consultant [Member] | Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         248,000  
Draganfly Innovations Shares [Member]            
IfrsStatementLineItems [Line Items]            
Stock issued during period value units, shares     8,527,671     8,517,671
Purchases of exercise of warrants   $ 1,645,193        
Vital Intelligence Inc [Member]            
IfrsStatementLineItems [Line Items]            
Share capital issuance, description       Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.   Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020
Number of stock units issued for acquisition       1,200,000    
Dronelogics Inc [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock units issued for acquisition         645,088  
Stock units issued during period shares common shares finder fees         40,000  
Common Stock 1 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants       1,580,525 24,000  
Value of stock issued for exercise of warrants       $ 3,951,312 $ 60,000  
Number of stock issued for restrcited share units       149,999 7,117  
Number of stock issued for exercise of options       392,999    
Value of stock issued for exercise of options       $ 987,248    
Number of shares issued       15,000   143,985
Proceeds from issuance of notes payable           $ 799,341
Subscription receivable           $ 153,566
Shares issued as transactions fees, shares           222,965
Amounts payable, related party transactions           $ 1,000,000
Common Stock 2 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants       359,009 20,000  
Value of stock issued for exercise of warrants       $ 978,478 $ 50,000  
Number of stock issued for restrcited share units       298,661 2,040  
Number of stock issued for exercise of options       12,500    
Value of stock issued for exercise of options       $ 26,875    
Number of shares issued       356,901    
Common Stock 3 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         210,320  
Value of stock issued for exercise of warrants         $ 105,160  
Number of stock issued for restrcited share units         2,647  
Common Stock 4 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         73,000  
Value of stock issued for exercise of warrants         $ 36,500  
Number of stock issued for restrcited share units         188,194  
Common Stock 5 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         294,840  
Value of stock issued for exercise of warrants         $ 147,420  
Common Stock 6 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         121,840  
Value of stock issued for exercise of warrants         $ 60,920  
Common Stock 7 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         126,000  
Value of stock issued for exercise of warrants         $ 115,000  
Common Stock 8 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         12,000  
Value of stock issued for exercise of warrants         $ 30,000  
Common Stock 9 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         45,600  
Value of stock issued for exercise of warrants         $ 114,000  
Common Stock 10 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         2,000  
Value of stock issued for exercise of warrants         $ 5,000  
Common Stock 11 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         2,200  
Value of stock issued for exercise of warrants         $ 5,500  
Common Stock 12 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         637,975  
Value of stock issued for exercise of warrants         $ 1,594,938  
Common Stock 13 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         15,000  
Value of stock issued for exercise of warrants         $ 37,500